These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 34731191)
41. Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins. Pirola CJ; Scian R; Gianotti TF; Dopazo H; Rohr C; Martino JS; Castaño GO; Sookoian S Medicine (Baltimore); 2015 Sep; 94(36):e1480. PubMed ID: 26356709 [TBL] [Abstract][Full Text] [Related]
42. TET1-GPER-PI3K/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation. Xie BY; Lv QY; Ning CC; Yang BY; Shan WW; Cheng YL; Gu C; Luo XZ; Zhang ZB; Chen XJ; Xi XW; Feng YJ Biochem Biophys Res Commun; 2017 Jan; 482(4):857-862. PubMed ID: 27889612 [TBL] [Abstract][Full Text] [Related]
43. Dynamic expression of TET1, TET2, and TET3 dioxygenases in mouse and human placentas throughout gestation. Rakoczy J; Padmanabhan N; Krzak AM; Kieckbusch J; Cindrova-Davies T; Watson ED Placenta; 2017 Nov; 59():46-56. PubMed ID: 29108636 [TBL] [Abstract][Full Text] [Related]
44. Effects of ten-eleven translocation 1 (Tet1) on DNA methylation and gene expression in chicken primordial germ cells. Yu M; Li D; Cao W; Chen X; Du W Reprod Fertil Dev; 2019 Mar; 31(3):509-520. PubMed ID: 30282572 [TBL] [Abstract][Full Text] [Related]
45. ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas. Mah V; Elshimali Y; Chu A; Moatamed NA; Uzzell JP; Tsui J; Schettler S; Shakeri H; Wadehra M Sci Rep; 2021 Jun; 11(1):11949. PubMed ID: 34099751 [TBL] [Abstract][Full Text] [Related]
46. Altering TET dioxygenase levels within physiological range affects DNA methylation dynamics of HEK293 cells. Grosser C; Wagner N; Grothaus K; Horsthemke B Epigenetics; 2015; 10(9):819-33. PubMed ID: 26186463 [TBL] [Abstract][Full Text] [Related]
47. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952 [TBL] [Abstract][Full Text] [Related]
48. Ten-eleven translocation protein 1 modulates medulloblastoma progression. Kim H; Kang Y; Li Y; Chen L; Lin L; Johnson ND; Zhu D; Robinson MH; McSwain L; Barwick BG; Yuan X; Liao X; Zhao J; Zhang Z; Shu Q; Chen J; Allen EG; Kenney AM; Castellino RC; Van Meir EG; Conneely KN; Vertino PM; Jin P; Li J Genome Biol; 2021 Apr; 22(1):125. PubMed ID: 33926529 [TBL] [Abstract][Full Text] [Related]
49. Elevated expression of ECT2 as a diagnostic marker and prognostic indicator in endometrial cancer. Wu XG; Wu Y; Pan YH; Chen JJ; Huang SY; Zhou XX; Zhong XQ; Ding ZA; Qiu YZ; Wang W; Fan LS Gene; 2024 Nov; 927():148756. PubMed ID: 38977110 [TBL] [Abstract][Full Text] [Related]
50. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma. Fujii S; Shinjo K; Matsumoto S; Harada T; Nojima S; Sato S; Usami Y; Toyosawa S; Morii E; Kondo Y; Kikuchi A Oncotarget; 2016 Dec; 7(49):81571-81587. PubMed ID: 27835592 [TBL] [Abstract][Full Text] [Related]
51. Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia. Zauber P; Denehy TR; Taylor RR; Ongcapin EH; Marotta S; Sabbath-Solitare M Int J Gynecol Cancer; 2015 Jun; 25(5):863-8. PubMed ID: 25768080 [TBL] [Abstract][Full Text] [Related]
52. TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma. Shirai K; Nagae G; Seki M; Kudo Y; Kamio A; Hayashi A; Okabe A; Ota S; Tsutsumi S; Fujita T; Yamamoto S; Nakaki R; Kanki Y; Osawa T; Midorikawa Y; Tateishi K; Ichinose M; Aburatani H Cancer Sci; 2021 Jul; 112(7):2855-2869. PubMed ID: 33970549 [TBL] [Abstract][Full Text] [Related]
53. Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells. Wang K; Chen Z; Shi J; Feng Y; Yu M; Sun Y; Zhuang Q; Liang B; Luo G; Xu X; Fan M Prostate; 2020 Sep; 80(12):977-985. PubMed ID: 32542727 [TBL] [Abstract][Full Text] [Related]
54. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin. Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825 [TBL] [Abstract][Full Text] [Related]
55. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer. Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725 [TBL] [Abstract][Full Text] [Related]
56. Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients. Yang Q; Wu K; Ji M; Jin W; He N; Shi B; Hou P J Biomed Nanotechnol; 2013 Sep; 9(9):1607-16. PubMed ID: 23980508 [TBL] [Abstract][Full Text] [Related]
57. Relationships between C-kit expression and mean platelet volume in benign, preneoplastic and neoplastic endometrium. Sehitoglu I; Bedir R; Ural UM; Gucer H; Yurdakul C; Cure MC; Cure E; Yuce S; Sahin FK Asian Pac J Cancer Prev; 2015; 16(4):1495-9. PubMed ID: 25743820 [TBL] [Abstract][Full Text] [Related]
58. Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance. Van Damme M; Crompot E; Meuleman N; Maerevoet M; Mineur P; Bron D; Lagneaux L; Stamatopoulos B Clin Epigenetics; 2016; 8():132. PubMed ID: 27980696 [TBL] [Abstract][Full Text] [Related]
59. Multiple Functions of Ten-eleven Translocation 1 during Tumorigenesis. Tian YP; Zhu YM; Sun XH; Lai MD Chin Med J (Engl); 2016 Jul; 129(14):1744-51. PubMed ID: 27411465 [TBL] [Abstract][Full Text] [Related]
60. TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer. Fu HL; Ma Y; Lu LG; Hou P; Li BJ; Jin WL; Cui DX J Biomed Nanotechnol; 2014 Jul; 10(7):1217-30. PubMed ID: 24804542 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]